Three-year Outcome of Children Exposed Prenatally to Drugs
Overview
Authors
Affiliations
Objective: To evaluate the 3-year behavioral and developmental outcome of children prenatally exposed to maternal substances of abuse.
Method: Ninety-three children exposed prenatally to cocaine and other drugs taken by the mother during pregnancy (Group 1), 24 polydrug/noncocaine exposed children (Group 2), and 25 nonexposed children (Group 3) were evaluated at 3 years of age as part of a longitudinal prospective study of the impact of intrauterine substance exposure on long-term outcome. The Stanford-Binet Intelligence Scale: Fourth Edition(SBIS) was administered by examiners blinded to the exposure background of the children, and a pediatrician performed a complete medical evaluation on all the children. The children's primary caregiver completed the Achenbach Child Behavior Checklist. Stepwise multiple regression procedures were used to determine the factors that best predicted 3-year growth, intelligence, and behavior.
Results: Groups 1 and 2 differed from Group 3 on head circumference. Group 1 scored lower than Group 3 on SBIS Verbal Reasoning. Group 2 scored Slower than Group 3 on SBIS Abstract/Visual Reasoning. Cocaine exposure predicted poor verbal reasoning. Marijuana exposure predicted poor abstract/visual reasoning. Examiner rating predicted intellectual outcome and caregiver ratings. Caregivers rated exposed children as more aggressive than nonexposed.
Conclusion: Contrary to information in the popular media, not all substance-exposed children suffer the same poor prognosis. In fact, generalizations about the fate of drug-exposed children must await additional research into the outcome of the broader population of drug-exposed children, examining the roles of maternal and environmental factors across a variety of geographic locations and socioeconomic levels.
Bailey B, Osborne J Front Pediatr. 2023; 11:1113047.
PMID: 36937971 PMC: 10017869. DOI: 10.3389/fped.2023.1113047.
Behavioral and Cognitive Differences in Early Childhood related to Prenatal Marijuana Exposure.
Murnan A, Keim S, Yeates K, Boone K, Sheppard K, Klebanoff M J Appl Dev Psychol. 2021; 77.
PMID: 34840377 PMC: 8622818. DOI: 10.1016/j.appdev.2021.101348.
DiGuiseppi C, Crume T, Van Dyke J, Sabourin K, Soke G, Croen L J Autism Dev Disord. 2021; 52(11):5064-5071.
PMID: 34767135 PMC: 9112286. DOI: 10.1007/s10803-021-05339-4.
Bauer C, Langer J, Lambert-Brown B, Shankaran S, Bada H, Lester B J Perinatol. 2020; 40(7):1056-1065.
PMID: 32444681 DOI: 10.1038/s41372-020-0692-3.
Parolin M, Simonelli A, Mapelli D, Sacco M, Cristofalo P Front Psychol. 2016; 7:887.
PMID: 27378983 PMC: 4909766. DOI: 10.3389/fpsyg.2016.00887.